PMI's IQOS Revenue Surpasses Marlboro, Aiming for 100B sales

Oct.11.2024
PMI's IQOS Revenue Surpasses Marlboro, Aiming for 100B sales
According to El Economista on October 9, Philip Morris International's IQOS device surpasses Marlboro in revenue, reaching $10 billion.

According to El Economista on October 9th, 38% of Philip Morris International's (PMI) global net income comes from non-cigarette alternative products. Revenue from their heated tobacco device "IQOS" has surpassed that of their most important cigarette brand Marlboro for the first time, with IQOS projected to exceed $10 billion in global sales by 2023.


It is reported that PMI's cigarette alternative products have now entered over 90 markets worldwide, with a total investment of $14 billion and a team of 1,500 people working on innovation.


The company's CEO, Jacek Olczak, stated during a media briefing in Neuchâtel, Switzerland, that...


The figures we have achieved are remarkable. Despite realizing that the market is developing faster than expected, there is still a long way to go.


Eujia further emphasized that it took IQOS 10 years to achieve sales of $10 billion, while Meta took 9 years, Amazon took 12 years, and Tesla took 14 years.


Philip Morris International (PMI) believes that there are 1.1 billion smokers worldwide and that the current measures being implemented are not effective enough. The IQOS device was initially launched in Milan, Italy, and Nagoya, Japan, and now has 30.8 million users. Oscar Jager stated, "In some countries, such as Japan, alternatives have already surpassed traditional cigarettes." He further emphasized that the company will continue to invest in new innovations to accelerate the transformation and aims to achieve 66% of revenue from alternatives by 2030.


However, the spokesperson acknowledged that due to insufficient information, many countries are skeptical of alternative products.


Some activists claim that these products are just as harmful as cigarettes, but we have proven that this is not true. People need to make informed decisions, as there is no scientific research indicating that these products are exactly the same as cigarettes.


Ouyaje criticized some government's strict regulation.


They refuse to listen to our advice because we are a tobacco company, but all of this is based on scientific data - nicotine does not cause cancer. This situation is similar to the COVID-19 vaccine, where some people are unwilling to get vaccinated despite scientific evidence.


He also stated that the World Health Organization "even refused to respond to our information".


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Court Formally Approves Imperial Tobacco Canada Restructuring Plan Involving US$23.6 Billion Settlement
U.S. Court Formally Approves Imperial Tobacco Canada Restructuring Plan Involving US$23.6 Billion Settlement
The U.S. Bankruptcy Court in New York has approved and recognized the restructuring plan of Imperial Tobacco Canada Ltd., granting legal effect in the U.S. to its participation in a CA$32.5 billion (US$23.6 billion) tobacco litigation settlement. The case is considered one of the largest corporate restructurings in Canadian history and also involves Japan Tobacco International (JTI), Philip Morris International (PMI), and British American Tobacco (BAT).
Aug.28 by 2FIRSTS.ai
Reuters: BAT to Launch Synthetic Nicotine Vape Vuse One in U.S., Hitting Shelves in Three States from Late September
Reuters: BAT to Launch Synthetic Nicotine Vape Vuse One in U.S., Hitting Shelves in Three States from Late September
British American Tobacco (BAT) plans to pilot sales of its disposable synthetic nicotine vape, Vuse One, in the United States, with launches expected in South Carolina, Florida, and Georgia in late September. The product has not yet received approval from the U.S. Food and Drug Administration (FDA). According to Reuters, this move marks a major shift in BAT’s stance after years of opposing the sale of unauthorized vapes. The company said the product will be distributed through major national ret
Aug.21 by 2FIRSTS.ai
Singapore May Tighten E-Cigarette Rules as Surge Detected in Products Laced with Anesthetic Etomidate
Singapore May Tighten E-Cigarette Rules as Surge Detected in Products Laced with Anesthetic Etomidate
Singapore plans to tighten vaping laws after detecting 28 etomidate-laced e-cigarette cases in H1 2025—nearly triple 2024’s total. Despite the 2018 ban, S$41 million worth of products were seized from Jan 2024 to Mar 2025, and a UN report shows rising etomidate e-cigarette use across East and Southeast Asia.
Jul.15 by 2FIRSTS.ai
Texas BISD Implements Strict Policy on E-Cigarettes, Mandating Minimum 10-Day Suspension or Alternative Education Program for Offending Students
Texas BISD Implements Strict Policy on E-Cigarettes, Mandating Minimum 10-Day Suspension or Alternative Education Program for Offending Students
Texas' Bryan Independent School District enforces strict e-cigarette policy, requiring at least 10-day suspension for violators.
Aug.08 by 2FIRSTS.ai
Sheffield Mini-Market Owner Given Suspended Sentence for Selling Illegal Tobacco and Vapes
Sheffield Mini-Market Owner Given Suspended Sentence for Selling Illegal Tobacco and Vapes
A Sheffield shop owner has narrowly avoided jail after being caught repeatedly selling counterfeit tobacco and oversized vapes. Following several inspections and raids by Sheffield City Council Trading Standards and South Yorkshire Police, more than 1,000 packs of illicit cigarettes, 265 pouches of hand-rolling tobacco, and 132 illegal vapes were seized.
Aug.22 by 2FIRSTS.ai
Product | 60,000 Puffs & Adjustable Settings: UWELL KOKO BAR 60K ICE Launches in U.S.
Product | 60,000 Puffs & Adjustable Settings: UWELL KOKO BAR 60K ICE Launches in U.S.
E-cigarette brand UWELL has launched the KOKO BAR 60K ICE disposable vape, offering 60,000 puffs with six levels of cooling intensity and five levels of nicotine strength adjustment, plus a 3D curved display. Now available on U.S. retailer websites at around $17.99.
Jul.14 by 2FIRSTS.ai